Logo
Give a Missed Call
+91 99532 12345
Logo
Give a Missed Call
+91 99532 12345
Login

Home

smallArrow

Stocks Screener

smallArrow

Medicamen Biotech

Medicamen Biotech Share Price

Medicamen Biotech (INR)531.4-19.4   (-3.5%)

Exchange ScripsBSE531146NSEMEDICAMEQISININE646B01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Medicamen Biotech Performance

Market performance
Open price551.6
High575.4
Volumes43221
Prev Close531.4
Low526
Closing date2024-10-16
Historical performance
1 Year High729.60
3 Year High1225.00
5 Year High1225.00
1 Year Low355.45
3 Year Low355.45
5 Year Low355.45

Medicamen Biotech Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
697
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
73.76
Dividend Yield
Dividend Yield
N/A

Medicamen Biotech Investment Returns

1 Year
-10.7%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Medicamen Biotech Technicals

IndicatorsValueSignal
5-DMA554.49Bearish
10-DMA558.51Bearish
20-DMA532.52Bearish
50-DMA464.64Bullish
100-DMA468.01Bullish
200-DMA482.64Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters11122
Foreign Investors---------------
Domestic Investors11122
Public Investors107911065110638102509417
Government---------------

Medicamen Biotech Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income2325178
Operating Profit258268258204
Interest57341915
Depreciation71645825
Profit Before Tax131170181164
Consolidated Net Profit95147149121
Adjusted EPS7121210

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital127127122122
Total Reserves1943178213431207
Minority Interest------------
Total Non-Current Liabilities576078
Total Liabilities2920276622521940
Capital Work in Progress------------
Total Assets2920276622521940

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities-67-6341128
Cash Flow from Investing Activities-56-59-85-178
Cash Flow from Financing Activitie632914358
Net Cash Inflow / Outflow-60170-18
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 73.76.
  • 3Y Stock Price CAGR of the stock is -0.1.
  • The stock has a beta of 1.3.
  • In the last financial year, the company had an EBITDA of ₹258 Million.
  • The company generated revenue of ₹1793 Million in the previous financial year.

Medicamen Biotech

531.4-19.4   (-3.5%)

Investment Amount: ₹ 61445
Current Value: ₹ 53140
Performence: -13.5%
P/L: ₹ -8305
Top Gainers
SymbolChange%
PREMIERPOL332.18(20%)
VAISHALI21.97(20%)
ANGELONE3236(18%)
AJMERA830.7(16%)
MOTILALOFS962.05(12%)
Top Losers
SymbolChange%
HAVISHA2.64(-8%)
SOMATEX45.58(-7%)
SHANTI17.37(-7%)
WEL1491.9(-6%)
ORIENTLTD114.7(-6%)
DBCORP333.35(-6%)
DELTAMAGNT98.78(-6%)
GODREJIND1058.75(-6%)
Similar stocks

Neuland Laboratories

▲ 25

16250.7

September 16 - October 16

RPG Life Sciences

▲ 24.2

2818.8

September 16 - October 16

Vaishali Pharma

▲ 20.2

21.97

September 16 - October 16

Strides Pharma Scien

▲ 15.6

1630.95

September 16 - October 16

Ipca Laboratories

▲ 15.5

1655.65

September 16 - October 16

Unichem Lab

▲ 13.9

727.1

September 16 - October 16

Astrazeneca Pharma I

▲ 12

7649.75

September 16 - October 16

Jagsonpal Pharma

▲ 11.4

449.4

September 16 - October 16

Announcing Stock of the Month!

Stock of the Month
Stock of the Month